{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:23:06Z","timestamp":1790518986389,"version":"4.1.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00109-021-02105-y","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T08:45:19Z","timestamp":1628498719000},"page":"1527-1538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["ABCB1 in dermatology: roles in skin diseases and their treatment"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7006-7599","authenticated-orcid":false,"given":"H. J.","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-1474","authenticated-orcid":false,"given":"T. F.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"2105_CR1","doi-asserted-by":"crossref","unstructured":"Liu X (2019) ABC family transporters. In: Liu X, Pan G (eds) Drug transporters in drug disposition, effects and toxicity. Springer, Singapore, pp 13\u2013100","DOI":"10.1007\/978-981-13-7647-4_2"},{"key":"2105_CR2","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","volume":"42","author":"M Dean","year":"2001","unstructured":"Dean M, Hamon Y, Chimini G (2001) The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42:1007\u20131017","journal-title":"J Lipid Res"},{"key":"2105_CR3","first-page":"1174","volume":"30","author":"JL Biedler","year":"1970","unstructured":"Biedler JL, Riehm H (1970) Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Can Res 30:1174\u20131184","journal-title":"Can Res"},{"key":"2105_CR4","doi-asserted-by":"crossref","unstructured":"Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V (1985) Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316:817\u2013819","DOI":"10.1038\/316817a0"},{"key":"2105_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ibmb.2013.11.001","volume":"45","author":"W Dermauw","year":"2014","unstructured":"Dermauw W, Van Leeuwen T (2014) The ABC gene family in arthropods: comparative genomics and role in insecticide transport and resistance. Insect Biochem Mol Biol 45:89\u2013110","journal-title":"Insect Biochem Mol Biol"},{"key":"2105_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","volume":"149","author":"R Silva","year":"2015","unstructured":"Silva R, Vilas-Boas V, Carmo H, Dinis-Oliveira RJ, Carvalho F, de Lourdes BM, Remi\u00e3o F (2015) Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacol Ther 149:1\u2013123","journal-title":"Pharmacol Ther"},{"key":"2105_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","volume":"77","author":"A Schinkel","year":"1994","unstructured":"Schinkel A, Smit J, van Tellingen M, Beijnen J, Wagenaar E, Van Deemter L, Mol C, Van der Valk M, Robanus-Maandag E, Te Riele H (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491\u2013502","journal-title":"Cell"},{"key":"2105_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.biocel.2011.12.009","volume":"44","author":"D Fu","year":"2012","unstructured":"Fu D, Arias IM (2012) Intracellular trafficking of P-glycoprotein. Int J Biochem Cell Biol 44:461\u2013464","journal-title":"Int J Biochem Cell Biol"},{"key":"2105_CR9","first-page":"47","volume":"9","author":"S Tulsyan","year":"2016","unstructured":"Tulsyan S, Mittal RD, Mittal B (2016) The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment. Pharmacogenomics Person Med 9:47","journal-title":"Pharmacogenomics Person Med"},{"key":"2105_CR10","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1111\/1759-7714.13184","volume":"10","author":"J Zhong","year":"2019","unstructured":"Zhong J, Guo Z, Fan L, Zhao X, Zhao B, Cao Z, Cheng L, Shi Y, Li X, Zhang Y (2019) ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy. Thorac Cancer 10:2088\u20132095","journal-title":"Thorac Cancer"},{"key":"2105_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00384-009-0724-0","volume":"24","author":"M Panczyk","year":"2009","unstructured":"Panczyk M, Balcerczak E, Piaskowski S, Jamroziak K, Pasz-Walczak G, Mirowski M (2009) ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer. Int J Colorectal Dis 24:895\u2013905","journal-title":"Int J Colorectal Dis"},{"key":"2105_CR12","doi-asserted-by":"crossref","unstructured":"Caronia D, Patino-Garcia A, Per\u00e9z-Mart\u00ednez A, Pita G, Moreno LT, Zalacain-D\u00edez M, Molina B, Colmenero I, Sierrases\u00famaga L, Ben\u00edtez J (2011) Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study. PLoS One 6:e26091","DOI":"10.1371\/journal.pone.0026091"},{"key":"2105_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/sj.tpj.6500413","volume":"7","author":"G Leschziner","year":"2007","unstructured":"Leschziner G, Andrew T, Pirmohamed M, Johnson M (2007) ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Pharmacogenomics J 7:154\u2013179","journal-title":"Pharmacogenomics J"},{"key":"2105_CR14","doi-asserted-by":"publisher","first-page":"31761","DOI":"10.1074\/jbc.M113.514091","volume":"288","author":"T Yamagishi","year":"2013","unstructured":"Yamagishi T, Sahni S, Sharp DM, Arvind A, Jansson PJ, Richardson DR (2013) P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration. J Biol Chem 288:31761\u201331771","journal-title":"J Biol Chem"},{"key":"2105_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1365-2133.1995.tb08710.x","volume":"132","author":"D Schadendorf","year":"1995","unstructured":"Schadendorf D, Herfordt R, Czarnetzki B (1995) P-glycoprotein expression in primary and metastatic malignant melanoma. Br J Dermatol 132:551\u2013555","journal-title":"Br J Dermatol"},{"key":"2105_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/CMR.0b013e3282a7e0b9","volume":"17","author":"S Heimerl","year":"2007","unstructured":"Heimerl S, Bosserhoff AK, Langmann T, Ecker J, Schmitz G (2007) Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Res 17:265\u2013273","journal-title":"Melanoma Res"},{"key":"2105_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ijc.2910590522","volume":"59","author":"W Berger","year":"1994","unstructured":"Berger W, Elbling L, Minai-Pour M, Vetterlein M, Pirker R, Kokoschka EM, Micksche M (1994) Intrinsic MDR-1 gene and P-glycoprotein expression in human melanoma cell lines. Int J Cancer 59:717\u2013723","journal-title":"Int J Cancer"},{"key":"2105_CR18","doi-asserted-by":"crossref","unstructured":"Wouters J, Stas M, Gremeaux L, Govaere O, Maes H, Agostinis P, Roskams T, van den Oord JJ, Vankelecom H (2013) The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis. PLoS One 8:e76550","DOI":"10.1371\/journal.pone.0076550"},{"key":"2105_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1755-148X.2011.00841.x","volume":"24","author":"S Landreville","year":"2011","unstructured":"Landreville S, Agapova OA, Kneass ZT, Salesse C, William Harbour J (2011) ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity. Pigment Cell Melanoma Res 24:430\u2013437","journal-title":"Pigment Cell Melanoma Res"},{"key":"2105_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11095-019-2695-3","volume":"36","author":"N Hashimoto","year":"2019","unstructured":"Hashimoto N, Nakamichi N, Nanmo H, Kimura K-i, Masuo Y, Sakai Y, Schinkel AH, Sato S, Soga T, Kato Y (2019) Metabolome analysis reveals dermal histamine accumulation in murine dermatitis provoked by genetic deletion of P-glycoprotein and breast cancer resistance protein. Pharm Res 36:158","journal-title":"Pharm Res"},{"key":"2105_CR21","doi-asserted-by":"crossref","unstructured":"Rychlik\u2010Sych M, Bara\u0144ska M, Dudarewicz M, Skr\u0119tkowicz J, \u017bebrowska A, Owczarek J, Waszczykowska E (2017) ABCB1 gene is associated with the risk of bullous pemphigoid in a polish population. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 15:499\u2013505","DOI":"10.1111\/ddg.13182"},{"key":"2105_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00403-018-1842-8","volume":"310","author":"M Rychlik-Sych","year":"2018","unstructured":"Rychlik-Sych M, Bara\u0144ska M, Dudarewicz M, Skr\u0119tkowicz J, \u017bebrowska A, Wo\u017aniacka A, Owczarek J, Orszulak-Michalak D, Waszczykowska E (2018) Haplotypes of ABCB1 1236C> T (rs1128503), 2677G> T\/A (rs2032582), and 3435C> T (rs1045642) in patients with bullous pemphigoid. Arch Dermatol Res 310:515\u2013522","journal-title":"Arch Dermatol Res"},{"key":"2105_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.gene.2012.05.040","volume":"505","author":"A Rustemoglu","year":"2012","unstructured":"Rustemoglu A, G\u00fcl \u00dc, G\u00fcm\u00fc\u015f-Akay G, G\u00f6n\u00fcl M, Yi\u011fit S, Bozkurt N, Karada\u011f A, Pi\u015fkin E, Sunguro\u011flu A, Kad\u0131k\u0131ran A (2012) MDR1 gene polymorphisms may be associated with Beh\u00e7et\u2019s disease and its colchicum treatment response. Gene 505:333\u2013339","journal-title":"Gene"},{"key":"2105_CR24","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/ijd.12540","volume":"53","author":"M Bonyadi","year":"2014","unstructured":"Bonyadi M, Gholizadeh M, Soltan-Ali M (2014) MDR 1 C3435T polymorphism associated with the development of clinical features in Beh\u00e7et\u2019s disease in Iranian Azeri Turkish patients. Int J Dermatol 53:1235\u20131240","journal-title":"Int J Dermatol"},{"key":"2105_CR25","doi-asserted-by":"crossref","unstructured":"Jana A, Thomas J, Ghosh P (2017) P-glycoprotein expression in oral lichen planus. Braz\u00a0Oral\u00a0Res 31","DOI":"10.1590\/1807-3107bor-2017.vol31.0095"},{"key":"2105_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1600-0625.2010.01237.x","volume":"20","author":"C Skazik","year":"2011","unstructured":"Skazik C, Wenzel J, Marquardt Y, Kim A, Merk HF, Bickers DR, Baron JM (2011) P-Glycoprotein (ABCB1) expression in human skin is mainly restricted to dermal components. Exp Dermatol 20:450\u2013452","journal-title":"Exp Dermatol"},{"key":"2105_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jconrel.2008.08.004","volume":"131","author":"K Ito","year":"2008","unstructured":"Ito K, Nguyen HT, Kato Y, Wakayama T, Kubo Y, Iseki S, Tsuji A (2008) P-glycoprotein (Abcb1) is involved in absorptive drug transport in skin. J Control Release 131:198\u2013204","journal-title":"J Control Release"},{"key":"2105_CR28","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.4049\/jimmunol.0900521","volume":"183","author":"H Wang","year":"2009","unstructured":"Wang H, Syrovets T, Kess D, B\u00fcchele B, Hainzl H, Lunov O, Weiss JM, Scharffetter-Kochanek K, Simmet T (2009) Targeting NF-\u03baB with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis. J Immunol 183:4755\u20134763","journal-title":"J Immunol"},{"key":"2105_CR29","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/1346-8138.13963","volume":"44","author":"K Mizuno","year":"2017","unstructured":"Mizuno K, Akimoto N, Kawamura M, Nakase K, Noguchi N, Sato T (2017) Involvement of adenosine triphosphate-binding cassette subfamily B member 1 in the augmentation of triacylglycerol excretion by Propionibacterium acnes in differentiated hamster sebocytes. J Dermatol 44:1404\u20131407","journal-title":"J Dermatol"},{"key":"2105_CR30","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/bjd.13549","volume":"172","author":"IS Haslam","year":"2015","unstructured":"Haslam IS, El-Chami C, Faruqi H, Shahmalak A, O\u2019Neill C, Paus R (2015) Differential expression and functionality of ATP-binding cassette transporters in the human hair follicle. Br J Dermatol 172:1562\u20131572","journal-title":"Br J Dermatol"},{"key":"2105_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ijpharm.2017.02.064","volume":"521","author":"N Hashimoto","year":"2017","unstructured":"Hashimoto N, Nakamichi N, Yamazaki E, Oikawa M, Masuo Y, Schinkel AH, Kato Y (2017) P-Glycoprotein in skin contributes to transdermal absorption of topical corticosteroids. Int J Pharm 521:365\u2013373","journal-title":"Int J Pharm"},{"key":"2105_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jconrel.2012.10.011","volume":"165","author":"N Hashimoto","year":"2013","unstructured":"Hashimoto N, Nakamichi N, Uwafuji S, Yoshida K, Sugiura T, Tsuji A, Kato Y (2013) ATP binding cassette transporters in two distinct compartments of the skin contribute to transdermal absorption of a typical substrate. J Control Release 165:54\u201361","journal-title":"J Control Release"},{"key":"2105_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.foodchem.2013.10.058","volume":"149","author":"C Yu","year":"2014","unstructured":"Yu C, Hsieh Y, Lin S, Chi Y, Hariharan P, Chao P, Hou Y (2014) Potential modulation on P-glycoprotein and CYP3A by soymilk and miso: in vivo and ex-vivo studies. Food Chem 149:25\u201330","journal-title":"Food Chem"},{"key":"2105_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1039\/C6FO00938G","volume":"8","author":"M-S Yang","year":"2017","unstructured":"Yang M-S, Yu C-P, Huang C-Y, Chao P-DL, Lin S-P, Hou Y-C (2017) Aloe activated P-glycoprotein and CYP 3A: a study on the serum kinetics of aloe and its interaction with cyclosporine in rats. Food Funct 8:315\u2013322","journal-title":"Food Funct"},{"key":"2105_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2478\/hepo-2013-0029","volume":"59","author":"A Bogacz","year":"2013","unstructured":"Bogacz A, Deka-Pawlik D, Bartkowiak-Wieczorek J, Karasiewicz M, Kujawski R, Kowalska A, Cha\u0142as A, Czerny B, Grze\u015bkowiak E, Mrozikiewicz PM (2013) The effect of herbal materials on the P-glycoprotein activity and function. Herba Polonica 59:129\u2013141","journal-title":"Herba Polonica"},{"key":"2105_CR36","doi-asserted-by":"crossref","unstructured":"Yang F, Dong X, Yin X, Wang W, You L, Ni J (2017) Radix Bupleuri: a review of traditional uses, botany, phytochemistry, pharmacology, and toxicology. Biomed\u00a0Res Int 2017","DOI":"10.1155\/2017\/7597596"},{"key":"2105_CR37","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3109\/00498254.2015.1117159","volume":"46","author":"C-P Yu","year":"2016","unstructured":"Yu C-P, Lin H-J, Lin S-P, Shia C-S, Chang P-H, Hou Y-C, Hsieh Y-W (2016) Rhubarb decreased the systemic exposure of cyclosporine, a probe substrate of P-glycoprotein and CYP 3A. Xenobiotica 46:677\u2013682","journal-title":"Xenobiotica"},{"key":"2105_CR38","doi-asserted-by":"crossref","unstructured":"Roma MI, Lampropulos VES, Ayll\u00f3n-Cabrera I, Sanabria ANS, Nigro MML, Peroni RN, Carballo MA (2019) Modulation of hepatic ABC transporters by Eruca vesicaria intake: potential diet-drug interactions. Food Chem\u00a0Toxicol\u00a0133:110797","DOI":"10.1016\/j.fct.2019.110797"},{"key":"2105_CR39","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1055\/s-0034-1383040","volume":"80","author":"Y-H Peng","year":"2014","unstructured":"Peng Y-H, Lin S-P, Yu C-P, Tsai S-Y, Chen M-Y, Hou Y-C, Chao P-DL (2014) Serum concentrations of anthraquinones after intake of Folium Sennae and potential modulation on P-glycoprotein. Planta Med 80:1291\u20131297","journal-title":"Planta Med"},{"key":"2105_CR40","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1039\/C6MB00187D","volume":"12","author":"S Mohana","year":"2016","unstructured":"Mohana S, Ganesan M, Agilan B, Karthikeyan R, Srithar G, Mary RB, Ananthakrishnan D, Velmurugan D, Prasad NR, Ambudkar SV (2016) Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer. Mol BioSyst 12:2458\u20132470","journal-title":"Mol BioSyst"},{"key":"2105_CR41","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1016\/j.ejmech.2009.02.027","volume":"44","author":"S Mares-S\u00e1mano","year":"2009","unstructured":"Mares-S\u00e1mano S, Badhan R, Penny J (2009) Identification of putative steroid-binding sites in human ABCB1 and ABCG2. Eur J Med Chem 44:3601\u20133611","journal-title":"Eur J Med Chem"},{"key":"2105_CR42","first-page":"19","volume":"46","author":"Y Abe","year":"2001","unstructured":"Abe Y, Shimizu K, Katayama I (2001) Significance of MDR1-Gene and P-glycoprotein (P-gp) expressions in the lesional skin of psoriasis vulgaris. Acta Med Nagasaki 46:19\u201324","journal-title":"Acta Med Nagasaki"},{"key":"2105_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1515\/dmdi-2013-0042","volume":"29","author":"H Osman-Ponchet","year":"2014","unstructured":"Osman-Ponchet H, Boulai A, Kouidhi M, Sevin K, Alriquet M, Gaborit A, Bertino B, Comby P, Ruty B (2014) Characterization of ABC transporters in human skin. Drug Metab Drug Interact 29:91\u2013100","journal-title":"Drug Metab Drug Interact"},{"key":"2105_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1179\/1120009X12Z.00000000010","volume":"24","author":"S Manceau","year":"2012","unstructured":"Manceau S, Giraud C, Decl\u00e8ves X, Batteux F, Ch\u00e9reau C, Chouzenoux S, Scherrmann J-M, Weill B, Perrot J-Y, Tr\u00e9luyer J-M (2012) Expression and induction by dexamethasone of ABC transporters and nuclear receptors in a human T-lymphocyte cell line. J Chemother 24:48\u201355","journal-title":"J Chemother"},{"key":"2105_CR45","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3109\/00498254.2016.1138249","volume":"46","author":"R Peng","year":"2016","unstructured":"Peng R, Zhang H, Zhang Y, Wei D-Y (2016) Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs. Xenobiotica 46:948\u2013952","journal-title":"Xenobiotica"},{"key":"2105_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/AAC.46.1.160-165.2002","volume":"46","author":"E-j Wang","year":"2002","unstructured":"Wang E-j, Lew K, Casciano CN, Clement RP, Johnson WW (2002) Interaction of common azole antifungals with P glycoprotein. Antimicrob Agents Chemother 46:160\u2013165","journal-title":"Antimicrob Agents Chemother"},{"key":"2105_CR47","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1002\/jps.22566","volume":"100","author":"JK Zolnerciks","year":"2011","unstructured":"Zolnerciks JK, Booth-Genthe CL, Gupta A, Harris J, Unadkat JD (2011) Substrate-and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions. J Pharm Sci 100:3055\u20133061","journal-title":"J Pharm Sci"},{"key":"2105_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/minf.200900075","volume":"29","author":"F Broccatelli","year":"2010","unstructured":"Broccatelli F, Carosati E, Cruciani G, Oprea TI (2010) Transporter-mediated efflux influences CNS side effects: ABCB1, from antitarget to target. Mol Inf 29:16\u201326","journal-title":"Mol Inf"},{"key":"2105_CR49","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1517\/13543784.10.3.547","volume":"10","author":"DK Agrawal","year":"2001","unstructured":"Agrawal DK (2001) Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug. Expert Opin Investig Drugs 10:547\u2013560","journal-title":"Expert Opin Investig Drugs"},{"key":"2105_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.15171\/apb.2016.017","volume":"6","author":"MM Abbasi","year":"2016","unstructured":"Abbasi MM, Valizadeh H, Hamishekar H, Mohammadnejad L, Zakeri-Milani P (2016) The effects of cetirizine on P-glycoprotein expression and function in vitro and in situ. Adv Pharm Bull 6:111","journal-title":"Adv Pharm Bull"},{"key":"2105_CR51","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1023\/A:1025092829696","volume":"20","author":"MD Perloff","year":"2003","unstructured":"Perloff MD, St\u00f6rmer E, von Moltke LL, Greenblatt DJ (2003) Rapid assessment of P-glycoprotein inhibition and induction in vitro. Pharm Res 20:1177\u20131183","journal-title":"Pharm Res"},{"key":"2105_CR52","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1021\/mp200026v","volume":"8","author":"X Ming","year":"2011","unstructured":"Ming X, Knight BM, Thakker DR (2011) Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters. Mol Pharm 8:1677\u20131686","journal-title":"Mol Pharm"},{"key":"2105_CR53","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1124\/dmd.107.017624","volume":"36","author":"Y Kitamura","year":"2008","unstructured":"Kitamura Y, Koto H, Matsuura S, Kawabata T, Tsuchiya H, Kusuhara H, Tsujimoto H, Sugiyama Y (2008) Modest effect of impaired P-glycoprotein on the plasma concentrations of fexofenadine, quinidine, and loperamide following oral administration in collies. Drug Metab Dispos 36:807\u2013810","journal-title":"Drug Metab Dispos"},{"key":"2105_CR54","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0090-9556(24)15235-X","volume":"27","author":"M Cvetkovic","year":"1999","unstructured":"Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB (1999) OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 27:866\u2013871","journal-title":"Drug Metab Dispos"},{"key":"2105_CR55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/jphp.12687","volume":"69","author":"F Li","year":"2017","unstructured":"Li F, Howard KD, Myers MJ (2017) Influence of P-glycoprotein on the disposition of fexofenadine and its enantiomers. J Pharm Pharmacol 69:274\u2013284","journal-title":"J Pharm Pharmacol"},{"key":"2105_CR56","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1046\/j.1365-2125.2002.01591.x","volume":"53","author":"S Drescher","year":"2002","unstructured":"Drescher S, Schaeffeler E, Hitzl M, Hofmann U, Schwab M, Brinkmann U, Eichelbaum M, Fromm MF (2002) MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol 53:526\u2013534","journal-title":"Br J Clin Pharmacol"},{"key":"2105_CR57","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.clpt.2004.08.002","volume":"76","author":"SY Yi","year":"2004","unstructured":"Yi SY, Hong KS, Lim HS, Chung JY, Oh DS, Kim JR, Jung HR, Cho JY, Yu KS, Jang IJ (2004) A variant 2677A allele of the MDR1 gene affects fexofenadine disposition. Clin Pharmacol Ther 76:418\u2013427","journal-title":"Clin Pharmacol Ther"},{"key":"2105_CR58","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1177\/0091270008319707","volume":"48","author":"S Liu","year":"2008","unstructured":"Liu S, Beringer PM, Hidayat L, Rao AP, Louie S, Burckart GJ, Shapiro B (2008) Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. J Clin Pharmacol 48:957\u2013965","journal-title":"J Clin Pharmacol"},{"key":"2105_CR59","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/cpt.718","volume":"102","author":"T Vanhove","year":"2017","unstructured":"Vanhove T, Bouillon T, de Loor H, Annaert P, Kuypers D (2017) Fexofenadine, a putative in vivo P-glycoprotein probe, fails to predict clearance of the substrate tacrolimus in renal recipients. Clin Pharmacol Ther 102:989\u2013996","journal-title":"Clin Pharmacol Ther"},{"key":"2105_CR60","doi-asserted-by":"publisher","first-page":"880","DOI":"10.5414\/CP201968","volume":"51","author":"KH Alzoubi","year":"2013","unstructured":"Alzoubi KH, KhabourQ OF, Sayer I, Mayyasl F (2013) The role of multidrug resistance-1 (MDR1) variants in response to fexofenadine among. Int J Clin Pharmacol Ther 51:880\u2013887","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2105_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13318-014-0236-3","volume":"41","author":"Y Xiong","year":"2016","unstructured":"Xiong Y, Yuan Z, Yang J, Xia C, Li X, Huang S, Zhang H, Liu M (2016) CYP3A5* 3 and MDR1 C3435T are influencing factors of inter-subject variability in rupatadine pharmacokinetics in healthy Chinese volunteers. Eur J Drug Metab Pharmacokinet 41:117\u2013124","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2105_CR62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2125.2006.02578.x","volume":"62","author":"G Gervasini","year":"2006","unstructured":"Gervasini G, Vizcaino S, Carrillo JA, Caballero MJ, Benitez J (2006) The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 C3435T polymorphisms and gender on the urinary excretion of the metabolites of the H1-receptor antihistamine ebastine: a pilot study. Br J Clin Pharmacol 62:177\u2013186","journal-title":"Br J Clin Pharmacol"},{"key":"2105_CR63","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1097\/MIB.0000000000000570","volume":"21","author":"M-N Lee","year":"2015","unstructured":"Lee M-N, Kang B, Choi SY, Kim MJ, Woo SY, Kim J-W, Choe YH, Lee S-Y (2015) Impact of genetic polymorphisms on 6-thioguanine nucleotide levels and toxicity in pediatric patients with IBD treated with azathioprine. Inflamm Bowel Dis 21:2897\u20132908","journal-title":"Inflamm Bowel Dis"},{"key":"2105_CR64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/s10165-009-0247-0","volume":"20","author":"S Tsujimura","year":"2010","unstructured":"Tsujimura S, Saito K, Nakayamada S, Tanaka Y (2010) Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis. Mod Rheumatol 20:139\u2013146","journal-title":"Mod Rheumatol"},{"key":"2105_CR65","doi-asserted-by":"crossref","unstructured":"Yan R-J, Lou T-T, Wu Y-F, Chen W-S (2017) Single nucleotide polymorphisms of ABCB1 gene and response to etanercept treatment in patients with ankylosing spondylitis in a Chinese Han population. Medicine 96","DOI":"10.1097\/MD.0000000000005929"},{"key":"2105_CR66","doi-asserted-by":"crossref","unstructured":"Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica Acta (BBA)-Biomembranes 455:152\u2013162","DOI":"10.1016\/0005-2736(76)90160-7"},{"key":"2105_CR67","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1002\/jps.22596","volume":"100","author":"P Mitra","year":"2011","unstructured":"Mitra P, Audus K, Williams G, Yazdanian M, Galinis D (2011) A comprehensive study demonstrating that p-glycoprotein function is directly affected by changes in pH: Implications for intestinal pH and effects on drug absorption. J Pharm Sci 100:4258\u20134268","journal-title":"J Pharm Sci"},{"key":"2105_CR68","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cbi.2014.04.009","volume":"218","author":"R Silva","year":"2014","unstructured":"Silva R, Carmo H, Vilas-Boas V, Barbosa DJ, Palmeira A, Sousa E, Carvalho F, de Lourdes BM, Remi\u00e3o F (2014) Colchicine effect on P-glycoprotein expression and activity: In silico and in vitro studies. Chem Biol Interact 218:50\u201362","journal-title":"Chem Biol Interact"},{"key":"2105_CR69","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3109\/0886022X.2011.605980","volume":"33","author":"F Ozen","year":"2011","unstructured":"Ozen F, Silan C, Uludag A, Candan F, Silan F, Ozdemir S, Atik S, Ozdemir O (2011) Association between ABCB1 (MDR1) gene 3435 C> T polymorphism and colchicine unresponsiveness of FMF patients. Ren Fail 33:899\u2013903","journal-title":"Ren Fail"},{"key":"2105_CR70","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/gtmb.2013.0293","volume":"18","author":"A Uludag","year":"2014","unstructured":"Uludag A, Silan C, Atik S, Akurut C, Uludag A, Silan F, Ozdemir O (2014) Relationship between response to colchicine treatment and MDR1 polymorphism in familial Mediterranean fever patients. Genet Test Mol Biomarkers 18:73\u201376","journal-title":"Genet Test Mol Biomarkers"},{"key":"2105_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4238\/vol10-1gmr824","volume":"10","author":"H Saricaoglu","year":"2011","unstructured":"Saricaoglu H, Yilmaz M, Karkucak M, Ozturk H, Yakut T, Gulten T, Baskan E, Aydogan K, Dilek K (2011) Investigation of ABCB 1 gene polymorphism with coichicine response in Behcet\u2019s disease. Genet Mol Res 10:1\u20136","journal-title":"Genet Mol Res"},{"key":"2105_CR72","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0009-9236(97)90027-8","volume":"62","author":"KS Lown","year":"1997","unstructured":"Lown KS, Mayo RR, Leichtman AB, Hl H, Turgeon DK, Schmiedlin-Ren P, Brown MB, Guo W, Rossi SJ, Benet LZ (1997) Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 62:248\u2013260","journal-title":"Clin Pharmacol Ther"},{"key":"2105_CR73","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1172\/JCI118214","volume":"96","author":"AH Schinkel","year":"1995","unstructured":"Schinkel AH, Wagenaar E, van Deemter L, Mol C, Borst P (1995) Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Investig 96:1698\u20131705","journal-title":"J Clin Investig"},{"key":"2105_CR74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clim.2010.10.001","volume":"138","author":"AP Diamanti","year":"2011","unstructured":"Diamanti AP, Rosado M, Germano V, Scarsella M, Giorda E, Podest\u00e0 E, D\u2019Amelio R, Carsetti R, Lagan\u00e0 B (2011) Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: Modulation of P-glycoprotein function. Clin Immunol 138:9\u201313","journal-title":"Clin Immunol"},{"key":"2105_CR75","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/15563650701779703","volume":"46","author":"G Eleftheriou","year":"2008","unstructured":"Eleftheriou G, Bacis G, Fiocchi R, Sebastiano R (2008) Colchicine-induced toxicity in a heart transplant patient with chronic renal failure. Clin Toxicol 46:827\u2013830","journal-title":"Clin Toxicol"},{"key":"2105_CR76","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/S0021-9258(18)53865-5","volume":"268","author":"CE Herzog","year":"1993","unstructured":"Herzog CE, Tsokos M, Bates S, Fojo A (1993) Increased mdr-1\/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J Biol Chem 268:2946\u20132952","journal-title":"J Biol Chem"},{"key":"2105_CR77","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bcpt.12371","volume":"117","author":"J Lee","year":"2015","unstructured":"Lee J, Wang R, Yang Y, Lu X, Zhang X, Wang L, Lou Y (2015) The Effect of ABCB 1 C 3435 T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis. Basic Clin Pharmacol Toxicol 117:117\u2013125","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2105_CR78","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/tpj.2014.23","volume":"14","author":"Y Vasilopoulos","year":"2014","unstructured":"Vasilopoulos Y, Sarri C, Zafiriou E, Patsatsi A, Stamatis C, Ntoumou E, Fassos I, Tsalta A, Karra A, Roussaki-Schulze A (2014) A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek population. Pharmacogenomics J 14:523","journal-title":"Pharmacogenomics J"},{"key":"2105_CR79","doi-asserted-by":"publisher","first-page":"462","DOI":"10.18433\/jpps31457","volume":"23","author":"BM Padhy","year":"2020","unstructured":"Padhy BM, Mohanty RR, Das S, Meher BR (2020) Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis: Ivermectin in COVID-19: A meta-analysis. J Pharm Pharm Sci 23:462\u2013469","journal-title":"J Pharm Pharm Sci"},{"key":"2105_CR80","doi-asserted-by":"crossref","unstructured":"Martin RJ, Robertson AP, Choudhary S (2020) Ivermectin: An Anthelmintic, an Insecticide, and Much More. Trends\u00a0Parasitol","DOI":"10.1016\/j.pt.2020.10.005"},{"key":"2105_CR81","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/ds.ds_27_18","volume":"37","author":"Y-W Chang","year":"2019","unstructured":"Chang Y-W, Tseng H-C (2019) The gift of honeymoon: An interesting case of furuncular myiasis caused by Dermatobia Hominis in Taiwan and review of the literature. Dermatol Sin 37:93","journal-title":"Dermatol Sin"},{"key":"2105_CR82","first-page":"30","volume":"42","author":"CN Burkhart","year":"2000","unstructured":"Burkhart CN (2000) Ivermectin: an assessment of its pharmacology, microbiology and safety. Vet Hum Toxicol 42:30\u201335","journal-title":"Vet Hum Toxicol"},{"key":"2105_CR83","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2885.2008.01007.x","volume":"32","author":"J Geyer","year":"2009","unstructured":"Geyer J, Gavrilova O, Petzinger E (2009) Brain penetration of ivermectin and selamectin in mdr1a, b P-glycoprotein-and bcrp-deficient knockout mice. J Vet Pharmacol Ther 32:87\u201396","journal-title":"J Vet Pharmacol Ther"},{"key":"2105_CR84","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1124\/dmd.109.030700","volume":"38","author":"S Kiki-Mvouaka","year":"2010","unstructured":"Kiki-Mvouaka S, Menez C, Borin C, Lyazrhi F, Foucaud-Vignault M, Dupuy J, Collet X, Alvinerie M, Lespine A (2010) Role of P-glycoprotein in the disposition of macrocyclic lactones: a comparison between ivermectin, eprinomectin, and moxidectin in mice. Drug Metab Dispos 38:573\u2013580","journal-title":"Drug Metab Dispos"},{"key":"2105_CR85","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13046-019-1251-7","volume":"38","author":"L Jiang","year":"2019","unstructured":"Jiang L, Wang P, Sun Y-J, Wu Y-J (2019) Ivermectin reverses the drug resistance in cancer cells through EGFR\/ERK\/Akt\/NF-\u03baB pathway. J Exp Clin Cancer Res 38:265","journal-title":"J Exp Clin Cancer Res"},{"key":"2105_CR86","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/jvp.12112","volume":"37","author":"M Ballent","year":"2014","unstructured":"Ballent M, Mat\u00e9 L, Virkel G, Sallovitz J, Viviani P, Lanusse C, Lifschitz A (2014) Intestinal drug transport: ex vivo evaluation of the interactions between ABC transporters and anthelmintic molecules. J Vet Pharmacol Ther 37:332\u2013337","journal-title":"J Vet Pharmacol Ther"},{"key":"2105_CR87","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1124\/dmd.105.007757","volume":"34","author":"M Ballent","year":"2006","unstructured":"Ballent M, Lifschitz A, Virkel G, Sallovitz J, Lanusse C (2006) Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments. Drug Metab Dispos 34:457\u2013463","journal-title":"Drug Metab Dispos"},{"key":"2105_CR88","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cbi.2005.11.002","volume":"159","author":"A Lespine","year":"2006","unstructured":"Lespine A, Dupuy J, Orlowski S, Nagy T, Glavinas H, Krajcsi P, Alvinerie M (2006) Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chem Biol Interact 159:169\u2013179","journal-title":"Chem Biol Interact"},{"key":"2105_CR89","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cbi.2010.05.013","volume":"186","author":"J Dupuy","year":"2010","unstructured":"Dupuy J, Alvinerie M, M\u00e9nez C, Lespine A (2010) Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells. Chem Biol Interact 186:280\u2013286","journal-title":"Chem Biol Interact"},{"key":"2105_CR90","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bcp.2011.10.010","volume":"83","author":"C M\u00e9nez","year":"2012","unstructured":"M\u00e9nez C, Mselli-Lakhal L, Foucaud-Vignault M, Balaguer P, Alvinerie M, Lespine A (2012) Ivermectin induces P-glycoprotein expression and function through mRNA stabilization in murine hepatocyte cell line. Biochem Pharmacol 83:269\u2013278","journal-title":"Biochem Pharmacol"},{"key":"2105_CR91","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cbi.2013.03.009","volume":"203","author":"L Luo","year":"2013","unstructured":"Luo L, Sun Y-J, Yang L, Huang S, Wu Y-J (2013) Avermectin induces P-glycoprotein expression in S2 cells via the calcium\/calmodulin\/NF-\u03baB pathway. Chem Biol Interact 203:430\u2013439","journal-title":"Chem Biol Interact"},{"key":"2105_CR92","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2350-11-111","volume":"11","author":"W Kudzi","year":"2010","unstructured":"Kudzi W, Dodoo AN, Mills JJ (2010) Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans? BMC Med Genet 11:111","journal-title":"BMC Med Genet"},{"key":"2105_CR93","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4269\/ajtmh.2010.09-0734","volume":"83","author":"C Bourguinat","year":"2010","unstructured":"Bourguinat C, Kamgno J, Boussinesq M, Mackenzie CD, Prichard RK, Geary TG (2010) Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event. Am J Trop Med Hyg 83:28\u201332","journal-title":"Am J Trop Med Hyg"},{"key":"2105_CR94","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMc1917344","volume":"383","author":"E Baudou","year":"2020","unstructured":"Baudou E, Lespine A, Durrieu G, Andr\u00e9 F, Gandia P, Durand C, Cunat S (2020) Serious ivermectin toxicity and human ABCB1 nonsense mutations. N Engl J Med 383:787\u2013789","journal-title":"N Engl J Med"},{"key":"2105_CR95","doi-asserted-by":"crossref","unstructured":"Qin K, Chen K, Zhao W, Zhao X, Luo J, Wang Q, Gao C, Li X, Wang C (2018) Methotrexate combined with 4-hydroperoxycyclophosphamide downregulates multidrug-resistance P-glycoprotein expression induced by methotrexate in rheumatoid arthritis fibroblast-like synoviocytes via the JAK2\/STAT3 pathway. J\u00a0Immunol\u00a02018","DOI":"10.1155\/2018\/3619320"},{"key":"2105_CR96","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/tpj.2014.81","volume":"15","author":"J Gregers","year":"2015","unstructured":"Gregers J, Green H, Christensen I, Dalhoff K, Schroeder H, Carlsen N, Rosthoej S, Lausen B, Schmiegelow K, Peterson C (2015) Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia. Pharmacogenomics J 15:372\u2013379","journal-title":"Pharmacogenomics J"},{"key":"2105_CR97","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1111\/jdv.16440","volume":"34","author":"M Chen","year":"2020","unstructured":"Chen M, Chen W, Liu P, Yan K, Lv C, Zhang M, Lu Y, Qin Q, Kuang Y, Zhu W (2020) The impacts of gene polymorphisms on methotrexate in Chinese psoriatic patients. J Eur Acad Dermatol Venereol 34:2059\u20132065","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2105_CR98","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1007\/s10067-017-3728-0","volume":"36","author":"M Garc\u00eda-Carrasco","year":"2017","unstructured":"Garc\u00eda-Carrasco M, Mendoza-Pinto C, Mac\u00edas-D\u00edaz S, Etchegaray-Morales I, M\u00e9ndez-Mart\u00ednez S, Soto-Santill\u00e1n P, P\u00e9rez-Romano B, Jim\u00e9nez-Herrera EA, Guzm\u00e1n-Ruiz O, Ruiz-Arg\u00fcelles A (2017) Clinical relevance of P-glycoprotein activity on peripheral blood mononuclear cells and polymorphonuclear neutrophils to methotrexate in systemic lupus erythematosus patients. Clin Rheumatol 36:2267\u20132272","journal-title":"Clin Rheumatol"},{"key":"2105_CR99","first-page":"943","volume":"35","author":"E Houlder","year":"2017","unstructured":"Houlder E, Millier M, Highton J, Gwynne-Jones D, Stamp L, Hessian P (2017) Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules. Clin Exp Rheumatol 35:943\u2013947","journal-title":"Clin Exp Rheumatol"},{"key":"2105_CR100","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/bdd.1927","volume":"36","author":"K Inami","year":"2015","unstructured":"Inami K, Sasaki T, Kumagai T, Nagata K (2015) Simultaneous evaluation of human CYP3A4 and ABCB1 induction by reporter assay in LS174T cells, stably expressing their reporter genes. Biopharm Drug Dispos 36:139\u2013147","journal-title":"Biopharm Drug Dispos"},{"key":"2105_CR101","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10637-010-9512-5","volume":"30","author":"L Zhang","year":"2012","unstructured":"Zhang L, Yan Y, Zhu D, Yang W, Wang W, Hu Y, Yang B, He Q (2012) Nutlin-1 strengthened anti-proliferation and differentiation-inducing activity of ATRA in ATRA-treated p-glycoprotein deregulated human myelocytic leukemia cells. Invest New Drugs 30:37\u201347","journal-title":"Invest New Drugs"},{"key":"2105_CR102","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3233\/JAD-150469","volume":"48","author":"M Kuntz","year":"2015","unstructured":"Kuntz M, Candela P, Saint-Pol J, Lamartiniere Y, Boucau M-C, Sevin E, Fenart L, Gosselet F (2015) Bexarotene promotes cholesterol efflux and restricts apical-to-basolateral transport of amyloid-\u03b2 peptides in an in vitro model of the human blood-brain barrier. J Alzheimers Dis 48:849\u2013862","journal-title":"J Alzheimers Dis"},{"key":"2105_CR103","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.tiv.2008.01.004","volume":"22","author":"F Klamt","year":"2008","unstructured":"Klamt F, Passos DT, Castro MAA, Gelain DP, Grivicich I, Moreira JCF (2008) Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line. Toxicol In Vitro 22:873\u2013878","journal-title":"Toxicol In Vitro"},{"key":"2105_CR104","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.trim.2012.03.006","volume":"27","author":"Y Li","year":"2012","unstructured":"Li Y, Hu X, Cai B, Chen J, Bai Y, Tang J, Liao Y, Wang L (2012) Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients. Transpl Immunol 27:12\u201318","journal-title":"Transpl Immunol"},{"key":"2105_CR105","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3899\/jrheum.090048","volume":"37","author":"K Suzuki","year":"2010","unstructured":"Suzuki K, Saito K, Tsujimura S, Nakayamada S, Yamaoka K, Sawamukai N, Iwata S, Nawata M, Nakano K, Tanaka Y (2010) Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis. J Rheumatol 37:512\u2013520","journal-title":"J Rheumatol"},{"key":"2105_CR106","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/bbrc.1993.1013","volume":"190","author":"M Kavallaris","year":"1993","unstructured":"Kavallaris M, Madafiglio J, Norris M, Haber M (1993) Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells. Biochem Biophys Res Commun 190:79\u201385","journal-title":"Biochem Biophys Res Commun"},{"key":"2105_CR107","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1006\/abbi.1996.0365","volume":"333","author":"AM George","year":"1996","unstructured":"George AM, Davey MW, Mir AA (1996) Functional expression of the human MDR1 gene in Escherichia coli. Arch Biochem Biophys 333:66\u201374","journal-title":"Arch Biochem Biophys"},{"key":"2105_CR108","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1128\/AAC.46.3.755-761.2002","volume":"46","author":"KL Mealey","year":"2002","unstructured":"Mealey KL, Barhoumi R, Burghardt RC, Safe S, Kochevar DT (2002) Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells. Antimicrob Agents Chemother 46:755\u2013761","journal-title":"Antimicrob Agents Chemother"},{"key":"2105_CR109","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/epi.12655","volume":"55","author":"XJ He","year":"2014","unstructured":"He XJ, Jian LY, He XL, Tang M, Wu Y, Xu YY, Sun XJ, Zhao LM (2014) Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced S tevens-J ohnson syndrome\/toxic epidermal necrolysis in C hinese H an patients with epilepsy. Epilepsia 55:1301\u20131306","journal-title":"Epilepsia"},{"key":"2105_CR110","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s00228-013-1549-x","volume":"69","author":"C Ciccacci","year":"2013","unstructured":"Ciccacci C, Di Fusco D, Marazzi MC, Zimba I, Erba F, Novelli G, Palombi L, Borgiani P, Liotta G (2013) Association between CYP2B6 polymorphisms and Nevirapine-induced SJS\/TEN: a pharmacogenetics study. Eur J Clin Pharmacol 69:1909\u20131916","journal-title":"Eur J Clin Pharmacol"},{"key":"2105_CR111","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5114\/ceji.2018.77393","volume":"43","author":"\u00dc Ya\u015far","year":"2018","unstructured":"Ya\u015far \u00dc (2018) The role of pharmacogenetics of cytochrome P450s in phenytoin-induced DRESS syndrome. Cent Eur J Immunol 43:220","journal-title":"Cent Eur J Immunol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02105-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-021-02105-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02105-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T19:01:42Z","timestamp":1744138902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-021-02105-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":111,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["2105"],"URL":"https:\/\/doi.org\/10.1007\/s00109-021-02105-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"17 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Tsen-Fang Tsai conducted clinical trials and received honoraria for serving as a consultant for Abbvie, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli-Lilly, Galderma, Janssen-Cilag, Merck Sharp & Dohme, Novartis International AG, Pfizer Inc., and UCB Pharma. Dr. Hao-Jui Weng has no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}